A new 'living guideline' from the American College of Physicians (ACP) recommends semaglutide (Wegovy) and tirzepatide (Zepbound) as first-line medications for adults with obesity.
Continue reading at Medical News Today.
Wegovy, Zepbound Named First Choice For Obesity Treatment In New Gu…
